Kewaunee Scientific (KEQU)
(Delayed Data from NSDQ)
$44.01 USD
-1.59 (-3.49%)
Updated Sep 19, 2025 03:57 PM ET
After-Market: $44.15 +0.14 (0.32%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
KEQU 44.01 -1.59(-3.49%)
Will KEQU be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KEQU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KEQU
Kewaunee Scientific Q1 Earnings Rise Y/Y, Stock Slides 19%
The Zacks Analyst Blog Highlights Lowe's, Bristol-Myers Squibb, Marvell Technology and Kewaunee Scientific
KEQU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top Research Reports for Lowe's, Bristol-Myers & Marvell Technology
Kewaunee Upgraded to Outperform on Nu Aire Synergies, Backlog
The Zacks Analyst Blog Highlights NVIDIA, Palantir, Coca-Cola, Kewaunee Scientific and Natural Health Trends
Other News for KEQU
Stochastic Reached Oversold appears for KEQU after 3.49% move
Shooting Star Candlestick appears for KEQU after 0.77% move
Is KEQU preparing to trend lower? Non-ADX 1,2,3,4 Bearish shows up after slipping 1.13%
Is KEQU ready to move higher? Stochastic Buy Signal shows up after climbing 1.03%
KEQU forms Lower Bollinger Band Walk on September 15